The modern paradigm of phototherapy

Clinics in Dermatology

Volumn 21, Issue 5, 2003, Pages 398-406

  Zanolli, Michael ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Neurologic Consultants PC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; BERGAPTEN; METHOXSALEN; PHOTOFRIN II; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; PSORALEN DERIVATIVE;

ABSORPTION SPECTROPHOTOMETRY; ACNE; ACTINIC KERATOSIS; ANTIGEN PRESENTING CELL; ATOPIC DERMATITIS; BIOLOGY; CANCER; CLINICAL TRIAL; DERMATOLOGY; DEVICE; DIGESTIVE SYSTEM CANCER; DNA DAMAGE; DNA REPLICATION; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; INFRARED RADIATION; ISOMERIZATION; LANGERHANS CELL; LOW LEVEL LASER THERAPY; LUNG CARCINOMA; MELANOMA; NAUSEA; PHOTOCHEMOTHERAPY; PHOTODERMATOSIS; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUVA; REVIEW; SIDE EFFECT; SKIN DISEASE; SUNLIGHT; T CELL LYMPHOMA; T LYMPHOCYTE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET C RADIATION; VITILIGO; VOMITING;

EID: 0348109476     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2003.08.005     Document Type: Article

References (35)

1. Anderson R.R., Parrish J.A. Selective photothermolysis precise microsurgery by selective absorption of pulsed radiation . Science. 220:1983;524-527.
2. Fisher T. UV light treatment of psoriasis. Acta Derm Venereol. 56:1976;473-479.
3. Parrish JA, Jaenicke KF, Action spectrum for phototherapy of psoriasis. J Invest Dermatol. 76:1981;359-362.
4. Walters I.B., Burack L.H., Coven T.R., et al. Suberythemogenic narrow band UVB is markedly more effective than conventional UVB treatment of psoriasis vulgaris. J Am Acad Dermatol. 40:1999;893-900.
5. Ozawa M., Ferenczi K., Kikuchi T., et al. 312 nm UV induces apoptosis of T cells. J Exp Med. 189:1999;711-718.
6. Hofer A., Fink-Puches R., Kerl H., et al. Comparison of phototherapy with near vs. far erythemogenic doses of narrow-band ultraviolet B in patients with psoriasis. Br J Dermatol. 138:1998;96-100.
7. Duthie M.S., Kimber I., Norval M. The effects of ultraviolet radiation on the human immune system. Br J Dermatol. 140:1999;995-1009.
8. Parrish J.A., Fitzpatrick T.B., Tanenbaum L., et al. Photochemotherapy of psoriasis with oral methoxsalen and long-wave ultraviolet light. N Engl J Med, 291:1974;1207-1211.
9. Tanew A., Ortel B., Rappersberger K., et al. 5-methoxypsoralen for photochemotherapy. J Am Acad Dermatol. 18:1988;333-338.
10. Stern R.S., Laird N. The carcinogenic risks of treatments for severe psoriasis. Cancer. 73:1994;2759-2764.
11. Stern R.S., Nichols K.P., Vakeva L.H. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med. 336:1997;1041-1045.
12. Cristofolini M., Recchia G., Goie S., et al. 6-Methylangelicins new monofunctional photochemotherapeuitc agents for psoriasis . Br J Dermatol. 122:1990;513-524.
13. Green C., Ferguson J., Lakshmipathi T., Johnson B.E. 311Nm. UVB phototherapy - an effective treatment for psoriasis. Br J Dermatol. 119:1988;691-696.
14. Larko O. Treatment of psoriasis with new UVB lamp. Acta Derm Venereol. 69:1989;357-359.
15. Tanew A., Radakovic-Fijan S., Schemper M., et al. Narrow band UVB phototherapy versus photochemotherapy in the treatment of chronic plaque psoriasis. Arch Dermatol. 135:1999;519-524.
16. Dawes R.S., Wainwright N.J., Cameron H., Ferguson J. Narrowband ultraviolet B phototherapy for chronic plaque psoriasis three times or five times weekly treatment? Br J Dermatol. 138:1998;833-839.
17. Asawanonda P., Anderson R.R., Chang Y., Taylor C.R. 308 nm excimer laser for the treatment of psoriasis a dose-response study . Arch Dermatol. 136:2000;619-624.
18. Trehan M., Taylor C.R. High-dose 308 nm laser for the treatment of psoriasis. J Am Acad Dermatol. 46:2002;732-737.
19. Feldman S.R., Mellen B.G., Housman T.S., et al. Efficacy of the 308 nm excimer laser for treatment of psoriasis results of a multicenter study . J Am Acad Dermatol. 46:2002;900-906.
20. Anderson R.R., Parish J.A. The optics of even skin. J Invest Dermatol. 77:1981;13-19.
21. Krutmann J., Cjeck W., Diepgen T., et al. High-dose UVA-1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol. 26:1992;225-230.
22. Morita A., Werfel P., Stege H., et al. J Exp Med. 186:1997;1763-1768.
23. Papgeorgiou P., Katsambas A., Chu A. Phototherapy with blue 415 nm and red 660 nm light in the treatment of acne vulgaris. British J Dermatol. 142:2000;973-978.
24. Kawada A., Aragane Y., Kameyama H., et al. Acne phototherapy with a high intensity enhanced narrowband blue light source an open study and in vitro investigation . J Dermatol. 30:2002;129-135.
25. Kennedy J.C., Puttier R.H., Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX basic principles and present clinical experience . J Photochem Photobiol. 6:1990;143-148.
26. Morton C.A., Mackie R.M., Whitehurst C., et al. Photodynamic therapy for basal cell carcinoma effects of tumor thickness and duration of photosensitizer application on response . Arch Dermatol. 134:1998;248-249.
27. Morton C.A., Whitehurst C., Moseley H., et al. Comparison of photodynamic therapy with cryotherapy in the treatmen of Bowen's disease. Br J Dermatol. 135:1996;766-771.
28. Fritsch C., Goerz G., Ruzicka T. Photodynamic therapy in dermatology. Arch Dermatol. 134:1998;207-214.
29. Ibbotson S.H. Topical 5 amino levulonic acid photodynamic therapy for the treatment of skin conditions other than non melanoma skin cancers. Br J Dermatol. 146:2002;178-188.
30. Pass H.I. Photodynamic therapy in oncology mechanisms and clinical use . J Natl Cancer Inst. 85:1993;443-456.
31. Houle J.M., Strong H.A. Duration of skin photosensitivity and incidence of photosensitivity reactions after administration of verteporfin. Retina. 22:2002;691-697.
32. Dougherty T.J. Photosensitizers therapy and detection of malignant tumors . Photochem Photobiol. 45:1987;879-889.
33. Divaris D., Kennedy J.C., Pottier R.H. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5 ALA correlates with localized protoporphyrin IX fluorescence. Am J Pathol. 136:1990;891-897.
34. Fritsch C., Verwohlt B., Bolsen K., et al. Influence of topical photosynamic therapy with 5ALA on porphyrin metabolism. Arch Dermatol Res. 288:1996;517-521.
35. Peng Q., Berg K., Moon J., et al. 5ALA acid-based photodynamic therapy principles and experimental research . Photochem Photobiol. 65:1997;235-251.